<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.4"?>
<!-- generated-on="2026-05-04T07:28:03+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.4" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://news.medxy.ai/cancer-risk-in-familial-adenomatous-polyposis-remains-broad-despite-preventive-surgery-dutch-nationwide-data-highlight-rising-gastric-cancer-burden/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T21:31:18-07:00</news:publication_date><news:title>Cancer Risk in Familial Adenomatous Polyposis Remains Broad Despite Preventive Surgery: Dutch Nationwide Data Highlight Rising Gastric Cancer Burden</news:title></news:news></url>
<url><loc>https://news.medxy.ai/pediatric-ischemic-stroke-in-switzerland-is-still-diagnosed-too-late-for-reperfusion-in-most-cases/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T21:27:02-07:00</news:publication_date><news:title>Pediatric Ischemic Stroke in Switzerland Is Still Diagnosed Too Late for Reperfusion in Most Cases</news:title></news:news></url>
<url><loc>https://news.medxy.ai/status-epilepticus-mortality-in-u-s-adults-is-rising-with-the-highest-burden-in-older-adults-men-non-hispanic-black-populations-and-the-south/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T21:24:38-07:00</news:publication_date><news:title>Status Epilepticus Mortality in U.S. Adults Is Rising, With the Highest Burden in Older Adults, Men, Non-Hispanic Black Populations, and the South</news:title></news:news></url>
<url><loc>https://news.medxy.ai/first-time-seizure-is-linked-to-a-markedly-increased-short-term-risk-of-occult-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T19:21:07-07:00</news:publication_date><news:title>First-Time Seizure Is Linked to a Markedly Increased Short-Term Risk of Occult Cancer</news:title></news:news></url>
<url><loc>https://news.medxy.ai/combined-nicotinamide-riboside-and-home-based-exercise-improved-peak-vo2-safely-in-friedreichs-ataxia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T18:49:30-07:00</news:publication_date><news:title>Combined Nicotinamide Riboside and Home-Based Exercise Improved Peak VO2 Safely in Friedreich&#8217;s Ataxia</news:title></news:news></url>
<url><loc>https://news.medxy.ai/teprotumumab-for-thyroid-eye-disease-carries-a-measurable-long-term-dysglycemia-risk/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T18:36:21-07:00</news:publication_date><news:title>Teprotumumab for Thyroid Eye Disease Carries a Measurable Long-Term Dysglycemia Risk</news:title></news:news></url>
<url><loc>https://news.medxy.ai/gut-microbiome-signatures-may-help-explain-why-gestational-diabetes-raises-later-type-2-diabetes-risk-in-hispanic-latina-women/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T18:34:27-07:00</news:publication_date><news:title>Gut Microbiome Signatures May Help Explain Why Gestational Diabetes Raises Later Type 2 Diabetes Risk in Hispanic/Latina Women</news:title></news:news></url>
<url><loc>https://news.medxy.ai/urinary-free-cortisol-thresholds-sharpen-the-differential-diagnosis-of-acth-dependent-cushings-syndrome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T18:05:07-07:00</news:publication_date><news:title>Urinary Free Cortisol Thresholds Sharpen the Differential Diagnosis of ACTH-Dependent Cushing’s Syndrome</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em-4/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-03T17:03:57-07:00</news:publication_date><news:title>Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-03T17:03:57-07:00</news:publication_date><news:title>Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-03T17:03:57-07:00</news:publication_date><news:title>Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-03T17:03:57-07:00</news:publication_date><news:title>Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em</news:title></news:news></url>
<url><loc>https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes-4/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T17:01:16-07:00</news:publication_date><news:title>Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T17:01:16-07:00</news:publication_date><news:title>Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T17:01:16-07:00</news:publication_date><news:title>Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T17:01:16-07:00</news:publication_date><news:title>Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/visceral-fat-predicts-diabetic-kidney-disease-differently-in-men-and-women-with-a-high-risk-signal-in-leaner-men/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T15:15:32-07:00</news:publication_date><news:title>Visceral Fat Predicts Diabetic Kidney Disease Differently in Men and Women, With a High-Risk Signal in Leaner Men</news:title></news:news></url>
<url><loc>https://news.medxy.ai/pcsk9-inhibition-lowers-ldl-cholesterol-in-heterozygous-familial-hypercholesterolemia-regardless-of-ldl-receptor-variant-function/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-03T12:47:16-07:00</news:publication_date><news:title>PCSK9 Inhibition Lowers LDL Cholesterol in Heterozygous Familial Hypercholesterolemia Regardless of LDL Receptor Variant Function</news:title></news:news></url>
<url><loc>https://news.medxy.ai/development-and-validation-of-a-clinical-polygenic-risk-report-in-u-s-based-health-systems-for-8-cardiovascular-conditions/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-02T22:18:57-07:00</news:publication_date><news:title>Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions</news:title></news:news></url>
<url><loc>https://news.medxy.ai/glp-1-receptor-agonists-show-lower-heart-failure-risk-versus-dpp-4-inhibitors-in-type-2-diabetes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-02T21:35:58-07:00</news:publication_date><news:title>GLP-1 Receptor Agonists Show Lower Heart Failure Risk Versus DPP-4 Inhibitors in Type 2 Diabetes</news:title></news:news></url>
</urlset>
